https://safesupply.com/investors-2/
Investment Thesis
Safe Supply Streaming Co. Ltd. is a venture capital firm specializing in incubation, seed/startups, and early ventures. It prefers to invest in drugs, Pharmaceuticals, and tightly woven fabric sectors.
Founded in 2022 and is based in Vancouver, Canada.
Safe Supply seems like a very interesting opportunity with narcotics legalization and decriminalization globally. The venture capitalist is at the very early stages of setting up a platform to fight against the crisis surrounding drugs beyond the use of narcotics itself. The leadership team has extensive expertise and experience in navigating the complex landscape and the sensitive nature of the industry. Along with cannabis and psychedelics, the early-stage investor is developing the platform to support the entire safe supply ecosystem, including safe supply of drugs, preventive tools, medical treatments and therapies, consumer goods, food & beverages, and more. It is slowly gaining traction with increasing volume on the CSE and potentially listing on the larger exchanges, which would change the game. A very compelling investment opportunity is about to take off.
Long Description
With a mission to help bring a responsible end to the war on drugs, Safe Supply Streaming Co. Ltd. is investing in and incubating companies at the forefront of the third wave of drug policy reform. As jurisdictions around the world move to decriminalize, regulate, and legalize drugs, Safe Supply is investing in the infrastructure necessary to support the transition. From developing the facilities to analyze, manufacture, and distribute psychoactive compounds including the coca plant, to investing in the research and innovation to harness the potential, and minimize the harm, of these medicines, to constructing the clinical infrastructure to ensure safe and responsible access and treatment, Safe Supply is building a platform of tightly woven companies that will help save millions of lives and build a safer, healthier post-war on drugs worlds.
The common shares of Safe Supply Streaming Co Ltd. (SPLY) previously listed as Origin Therapeutics Holdings Inc. (ORIG) have been approved for listing on the CSE.
Executive Team
Went public through an RTO in September 2023
The Transaction was completed by way of a three-cornered amalgamation under the Canada Business Corporations Act, whereby the Company was amalgamated with the predecessor entity operating as Safe Supply Streaming Co. Ltd ("SSSC").
-
An aggregate of 5,965,000 subscription receipts of SSSC, which were issued pursuant to the previously announced concurrent private placement of SSSC for aggregate gross proceeds of $2,386,000 (the "Concurrent Financing"), were converted for no additional consideration into an aggregate of 5,965,000 Shares.
-
Shareholders of SSSC received one Share for every common share of SSSC held.
Following closing of the Transaction, the Company has 70,217,750 Shares outstanding, of which 14,140,750 Shares are held by the shareholders of Origin Therapeutics Inc. prior to the completion of the Transaction (and after a 4:1 consolidation of common shares of Origin Therapeutics Inc.) and 56,077,000 Shares (inclusive of subscribers in the Concurrent Financing) are held by the former shareholders of SSSC. In addition, an aggregate of 375,000 Shares are issuable upon the exercise of stock options of the Company and an aggregate of 434,750 Shares are issuable upon the exercise of compensation options or warrants granted to brokers, finders, or agents in connection with the Concurrent Financing.
Current Valuation
Safe Supply Streaming Co. is trading at ~C$0.11, implying ~C$7.724M with 70,217,750 shares outstanding.